Clinical Trial Update: Radiotherapy with Immunotherapy and Anti-Angiogenic Therapy for Advanced HER2-Negative Breast Cancer: a Single-Arm Study [Phase 1, Phase 2]

View source ↗

Summary

This is a single-arm Phase 1/2 clinical trial evaluating radiotherapy combined with immunotherapy and anti-angiogenic therapy for advanced HER2-negative metasta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Zhongnan Hospital | Conditions: Breast Cancer, Metastatic Breast Cancer | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION